173 related articles for article (PubMed ID: 12208604)
1. Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys.
Bhardwaj D; Hora B; Singh N; Puri SK; Lalitha P; Rupa P; Chauhan VS
FEMS Immunol Med Microbiol; 2002 Sep; 34(1):33-43. PubMed ID: 12208604
[TBL] [Abstract][Full Text] [Related]
2. DNA prime-protein boost immunization in monkeys: efficacy of a novel construct containing functional domains of Plasmodium cynomolgi CS and TRAP.
Bhardwaj D; Kushwaha A; Puri SK; Herrera A; Singh N; Chauhan VS
FEMS Immunol Med Microbiol; 2003 Dec; 39(3):241-50. PubMed ID: 14642309
[TBL] [Abstract][Full Text] [Related]
3. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.
Dutta S; Kaushal DC; Ware LA; Puri SK; Kaushal NA; Narula A; Upadhyaya DS; Lanar DE
Infect Immun; 2005 Sep; 73(9):5936-44. PubMed ID: 16113314
[TBL] [Abstract][Full Text] [Related]
4. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
[TBL] [Abstract][Full Text] [Related]
5. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
6. Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen.
Rogers WO; Weiss WR; Kumar A; Aguiar JC; Tine JA; Gwadz R; Harre JG; Gowda K; Rathore D; Kumar S; Hoffman SL
Infect Immun; 2002 Aug; 70(8):4329-35. PubMed ID: 12117942
[TBL] [Abstract][Full Text] [Related]
7. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.
Rogers WO; Baird JK; Kumar A; Tine JA; Weiss W; Aguiar JC; Gowda K; Gwadz R; Kumar S; Gold M; Hoffman SL
Infect Immun; 2001 Sep; 69(9):5565-72. PubMed ID: 11500430
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
[TBL] [Abstract][Full Text] [Related]
10. Strain-specific protective effect of the immunity induced by live malarial sporozoites under chloroquine cover.
Wijayalath W; Cheesman S; Tanabe K; Handunnetti S; Carter R; Pathirana S
PLoS One; 2012; 7(9):e45861. PubMed ID: 23029282
[TBL] [Abstract][Full Text] [Related]
11. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome.
Haddad D; Bilcikova E; Witney AA; Carlton JM; White CE; Blair PL; Chattopadhyay R; Russell J; Abot E; Charoenvit Y; Aguiar JC; Carucci DJ; Weiss WR
Infect Immun; 2004 Mar; 72(3):1594-602. PubMed ID: 14977966
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.
Sheikh IH; Kaushal DC; Chandra D; Kaushal NA
Acta Trop; 2016 Oct; 162():66-74. PubMed ID: 27311385
[TBL] [Abstract][Full Text] [Related]
13. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.
Rainczuk A; Scorza T; Smooker PM; Spithill TW
Infect Immun; 2003 Aug; 71(8):4506-15. PubMed ID: 12874330
[TBL] [Abstract][Full Text] [Related]
14. Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey.
Wijayalath WA; Cheesman S; Rajakaruna J; Handunnetti SM; Carter R; Pathirana PP
Parasite Immunol; 2008; 30(11-12):630-6. PubMed ID: 19067844
[TBL] [Abstract][Full Text] [Related]
15. Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.
Weiss WR; Kumar A; Jiang G; Williams J; Bostick A; Conteh S; Fryauff D; Aguiar J; Singh M; O'Hagan DT; Ulmer JB; Richie TL
PLoS One; 2007 Oct; 2(10):e1063. PubMed ID: 17957247
[TBL] [Abstract][Full Text] [Related]
16. DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses.
Baruch DI; Gamain B; Miller LH
Infect Immun; 2003 Aug; 71(8):4536-43. PubMed ID: 12874333
[TBL] [Abstract][Full Text] [Related]
17. Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens.
Rogers WO; Gowda K; Hoffman SL
Vaccine; 1999 Aug; 17(23-24):3136-44. PubMed ID: 10462250
[TBL] [Abstract][Full Text] [Related]
18. Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies.
Jiang G; Shi M; Conteh S; Richie N; Banania G; Geneshan H; Valencia A; Singh P; Aguiar J; Limbach K; Kamrud KI; Rayner J; Smith J; Bruder JT; King CR; Tsuboi T; Takeo S; Endo Y; Doolan DL; Richie TL; Weiss WR
PLoS One; 2009 Aug; 4(8):e6559. PubMed ID: 19668343
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, protective efficacy and safety of a recombinant DNA vaccine encoding truncated Plasmodium yoelii sporozoite asparagine-rich protein 1 (PySAP1).
Zhao J; Deng S; Liang J; Cao Y; Liu J; Du F; Shang H; Cui L; Luo E
Hum Vaccin Immunother; 2013 May; 9(5):1104-11. PubMed ID: 23357857
[TBL] [Abstract][Full Text] [Related]
20. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
Hedstrom RC; Doolan DL; Wang R; Kumar A; Sacci JB; Gardner MJ; Aguiar JC; Charoenvit Y; Sedegah M; Tine JA; Margalith M; Hobart P; Hoffman SL
Int J Mol Med; 1998 Jul; 2(1):29-38. PubMed ID: 9854139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
